胆红素纳米颗粒的药理作用研究进展
x
请在关注微信后,向客服人员索取文件
篇名: | 胆红素纳米颗粒的药理作用研究进展 |
TITLE: | Research progress on pharmacological effects of bilirubin nanoparticles |
摘要: | 胆红素具有良好的抗炎、抗氧化和免疫调节作用,但由于其水溶性差、生物利用度低,极大地限制了临床应用。研究人员将胆红素开发成各种纳米颗粒,借助剂型优势有效消除了胆红素溶解性低的限制,使其能够最大化地发挥抗炎、抗氧化、调节免疫等药理活性。胆红素纳米颗粒在多种胃肠道疾病、肝肾疾病、皮肤疾病、自身免疫性疾病、胰岛移植以及肿瘤的靶向治疗(既可直接抗肿瘤,又可作为药物递送系统)中均具有巨大的应用潜力。对胆红素纳米制剂的研究将推动胆红素的临床应用和相关的新药研发。 |
ABSTRACT: | Bilirubin has good anti-inflammatory, antioxidant and immunomodulatory effects, but its poor water solubility and low bioavailability greatly limit its clinical application. Researchers have developed bilirubin into various nanoparticles, which effectively eliminate the limitation of low solubility of bilirubin with the advantage of dosage form, so that they can maximize its pharmacological activities such as anti-inflammatory, anti-oxidation and immune regulation. Bilirubin nanoparticles have great application potential in a variety of gastrointestinal diseases, liver and kidney diseases, skin diseases, autoimmune diseases, islet transplantation and targeted therapy of tumors (both as a direct anti-tumor drug and as a drug delivery system). The study of bilirubin nanoparticles will promote the clinical application of bilirubin and the development of related new drugs. |
期刊: | 2023年第34卷第05期 |
作者: | 乔婷婷;张志宏;周俊发;叶仕高;曾元宁;王秋红 |
AUTHORS: | QIAO Tingting,ZHANG Zhihong,ZHOU Junfa,YE Shigao,ZENG Yuanning,WANG Qiuhong |
关键字: | 胆红素;纳米颗粒;抗炎;抗氧化;免疫调节;抗肿瘤;靶向治疗 |
KEYWORDS: | bilirubin; nanoparticles; anti-inflammatory; anti-oxidation; immune regulation; anti-tumor; targeted therapy |
阅读数: | 738 次 |
本月下载数: | 16 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!